Prelude Capital Management, LLC Inovio Pharmaceuticals, Inc. Transaction History

Prelude Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	BUY	$2.98 - $14.09 $2,980 - $14,090	1,000 New	1,000 $7,000
Q3 2019 Nov 14, 2019	SELL	$2.05 - $3.02 $7,092 - $10,449	-3,460 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$2.29 - $4.1 $7,923 - $14,185	3,460 New	3,460 $10,000
Q4 2017 Feb 14, 2018	SELL	$4.13 - $6.68 $11,977 - $19,372	-2,900 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$5.36 - $6.37 $15,544 - $18,473	2,900	2,900 $18,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.